Cargando…
Gene Therapy for Human Sensorineural Hearing Loss
Hearing loss is the most common sensory impairment in humans and currently disables 466 million people across the world. Congenital deafness affects at least 1 in 500 newborns, and over 50% are hereditary in nature. To date, existing pharmacologic therapies for genetic and acquired etiologies of dea...
Autores principales: | Ren, Yin, Landegger, Lukas D., Stankovic, Konstantina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660246/ https://www.ncbi.nlm.nih.gov/pubmed/31379508 http://dx.doi.org/10.3389/fncel.2019.00323 |
Ejemplares similares
-
Intracochlear Perfusion of Tumor Necrosis Factor-Alpha Induces Sensorineural Hearing Loss and Synaptic Degeneration in Guinea Pigs
por: Katsumi, Sachiyo, et al.
Publicado: (2020) -
Cochlin Deficiency Protects Against Noise-Induced Hearing Loss
por: Seist, Richard, et al.
Publicado: (2021) -
MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas
por: Ren, Yin, et al.
Publicado: (2020) -
Clinical characteristics and prognosis of acute low-frequency hearing loss and ascending sensorineural sudden sensorineural hearing loss
por: Diao, Tongxiang, et al.
Publicado: (2023) -
Accelerated Long-Term Hearing Loss Progression After Recovery From Idiopathic Sudden Sensorineural Hearing Loss
por: Early, Samuel, et al.
Publicado: (2021)